Adult Cystic Fybrosis Adult Cystic Fibrosis Conference, 2023

Changes in the cardiometabolic risk factors post elexacaftor-tezacaftor-ivacaftor therapy; a real-world prospective single center study.

Changes in the cardiometabolic risk factors post elexacaftor-tezacaftor-ivacaftor therapy; a real-world prospective single center study.